N-acetyl mannosammine as a therapeutic agent

US10953026B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• Marjan Huizing · Kensington, US
• William A. Gahl · Kensington, US
• Irini Manoli · Rockville, US
• Enriko Klootwijk · London, GB

Key dates

• Filing date: May 20, 2019
• Grant date: Mar 23, 2021
• Expiry date: May 20, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compositions and methods for treating kidney and muscle dysfunction that involves use of therapeutic amounts of N-acetyl mannosamine.